ATE334688T1 - Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung - Google Patents

Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung

Info

Publication number
ATE334688T1
ATE334688T1 AT01977046T AT01977046T ATE334688T1 AT E334688 T1 ATE334688 T1 AT E334688T1 AT 01977046 T AT01977046 T AT 01977046T AT 01977046 T AT01977046 T AT 01977046T AT E334688 T1 ATE334688 T1 AT E334688T1
Authority
AT
Austria
Prior art keywords
cornstarch
dysglucaemia
granulate
tablets
prevented
Prior art date
Application number
AT01977046T
Other languages
English (en)
Inventor
Henri Hansson
Kerstin Hansson
Mats Lake
Original Assignee
Metcon Medicin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003877A external-priority patent/SE0003877D0/xx
Application filed by Metcon Medicin Ab filed Critical Metcon Medicin Ab
Application granted granted Critical
Publication of ATE334688T1 publication Critical patent/ATE334688T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01977046T 2000-10-25 2001-10-24 Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung ATE334688T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24307200P 2000-10-25 2000-10-25
SE0003877A SE0003877D0 (sv) 2000-10-25 2000-10-25 New composition, method and use

Publications (1)

Publication Number Publication Date
ATE334688T1 true ATE334688T1 (de) 2006-08-15

Family

ID=26655276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01977046T ATE334688T1 (de) 2000-10-25 2001-10-24 Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (4) US6815433B2 (de)
EP (1) EP1328280B1 (de)
JP (1) JP2004512306A (de)
AT (1) ATE334688T1 (de)
AU (2) AU2001296196B2 (de)
CA (1) CA2422900A1 (de)
DE (1) DE60121981D1 (de)
WO (1) WO2002034271A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE334688T1 (de) * 2000-10-25 2006-08-15 Metcon Medicin Ab Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung
US20030158090A1 (en) * 2001-07-23 2003-08-21 Ulrik Pedersen-Bjergaard Renin-angiotensin system in diabetes mellitus
SE0200539D0 (sv) * 2002-02-25 2002-02-25 Metcon Medicin Ab Granulation process and starch granulate
WO2004024168A1 (en) * 2002-09-13 2004-03-25 Metcon Medicin Ab Composition and method for use in intestinal cleansing procedures
GB0325942D0 (en) * 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
SE0402084D0 (sv) * 2004-08-26 2004-08-26 Metcon Medicin Ab Method and composition for long-term glycemic control
CN101237874B (zh) * 2005-07-05 2013-10-09 努特里希亚公司 碳水化合物成分及其在获得平稳的餐后葡萄糖响应中的应用
US8557274B2 (en) * 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
EP2068636A4 (de) * 2006-09-18 2010-09-29 Purdue Research Foundation Gelockerte produkte, die aus nichtweizen-getreideproteinen hergestellt sind
JP5871447B2 (ja) * 2007-11-30 2016-03-01 花王株式会社 Ｇｉｐ分泌抑制剤
US8283338B2 (en) 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
EP2067466B1 (de) 2007-12-03 2012-08-15 Varatus Vongsurakrai Kosmetisches und/oder dermatologisches Pulver enthaltend modifizierte Stärke
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
JP5581129B2 (ja) * 2009-06-17 2014-08-27 花王株式会社 肥満予防・改善剤
EP2630491A4 (de) 2010-10-19 2014-08-27 Elcelyx Therapeutics Inc Auf chemosensorischen rezeptorliganden basierende therapien
CZ2013338A3 (cs) * 2013-05-09 2014-11-19 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice s řízeným uvolňováním metabolicky aktivního cukru

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886295A (en) * 1974-01-04 1975-05-27 Tee Pak Inc Low calorie synthetic seasoning
US4262031A (en) * 1979-08-17 1981-04-14 General Foods Corporation Cooked pudding composition containing highly-dutched cocoa and process
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5360614A (en) 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
IL112967A0 (en) * 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
US5843921A (en) * 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
JP3110299B2 (ja) * 1994-10-27 2000-11-20 武田薬品工業株式会社 成形物およびその製造方法
JP3119801B2 (ja) * 1995-09-28 2000-12-25 武田薬品工業株式会社 ビタミン含有組成物の安定化方法
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5842931A (en) 1996-02-12 1998-12-01 Payne; Edward D. Mirrored headgear sports training system
US5866555A (en) * 1997-03-12 1999-02-02 Beth Israel Deaconess Medical Center Diabetic supplement bar
US6316427B1 (en) * 2000-04-04 2001-11-13 Metcon Medicin Ab Treatment for diabetes
ATE334688T1 (de) * 2000-10-25 2006-08-15 Metcon Medicin Ab Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
WO2002034271A1 (en) 2002-05-02
US20050070502A1 (en) 2005-03-31
US20040198699A1 (en) 2004-10-07
EP1328280A1 (de) 2003-07-23
DE60121981D1 (de) 2006-09-14
CA2422900A1 (en) 2002-05-02
US6815436B2 (en) 2004-11-09
EP1328280B1 (de) 2006-08-02
AU2001296196B2 (en) 2006-07-06
US20020094971A1 (en) 2002-07-18
US6815433B2 (en) 2004-11-09
AU9619601A (en) 2002-05-06
JP2004512306A (ja) 2004-04-22
US20030004135A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
DE60121981D1 (de) Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung
Cardinali et al. Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications
CA2191714A1 (en) Therapeutic food composition and method to diminish blood sugar fluctuations
MY135783A (en) Nutritional composition for controlling blood sugar level
CA2269334A1 (en) Therapeutic food composition and method to diminish blood sugar fluctuations
JP4295840B2 (ja) 血行改善剤
DE60001745D1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
NO883204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner og isosterer derav.
EP1733734A3 (de) Plazentäre alkalische Phosphatase zur Diabeteskontrolle
US4309445A (en) d-Fenfluramine for modifying feeding behavior
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
MXPA02003495A (es) Derivados de piridinio para el manejo de complicaciones vasculares diabeticas y relacionadas con la edad, proceso para su preparacion, y usos terapeuticos de los mismos.
TW200500349A (en) Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals
CN107126411A (zh) 具有缓解神经性头痛作用的大麻二酚凝胶及其制备方法
CN100379872C (zh) 具有延长链和低血糖指数的异麦芽糖寡糖的制备方法
WO2000078724A3 (en) Imidazolinderivatives their preparation and their pharmaceutical use
AU776376B2 (en) Remedies for hyperammonemia
NO20054380L (no) Arylsykloalkylderivater med forgrenede sidekjeder som PPAR-reseptormodulatorer, deres fremstilling og deres anvendelse som legemiddel
JP2020100601A (ja) 一酸化窒素合成酵素活性化剤
NZ515173A (en) Treatment of hypersensitivity reaction disorders
CN118845824B (zh) 壳聚糖在制备有助于改善睡眠组合物中的应用
WO2003011119A3 (en) Methods and compositions for diagnosis and treatment of vascular conditions
JP7748715B2 (ja) 線維芽細胞増殖因子２１誘導剤、及びアルコール嗜好性又は単純糖質嗜好性を抑制するための組成物
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
HUP0203676A2 (hu) Eljárás és gyógyszerészeti készítmény diabetes kezeléséhez

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties